Core Insights - Blue Gold Limited has secured a gold supply agreement providing over 1 million ounces (31 Metric Tons) of gold, valued at approximately US $4.2 billion, to support the production and delivery of its Standard Gold Coin [1][3] - The partnership with DL Hudson Dunes, a Dubai-based commodity trader, enhances Blue Gold's logistics and supply-chain capabilities, crucial for delivering a digitally tradable, asset-backed gold product [2][5] - The CEO of Blue Gold emphasizes the commitment to transparency and customer experience in building the Standard Gold Coin into a dominant gold-backed token in the market [3] Company Overview - Blue Gold Limited is focused on acquiring high-potential mining assets globally and aims to unlock value in the gold sector through innovative monetization models, including asset-backed digital instruments [6] - The company prioritizes responsible development, operational transparency, and leveraging modern financial technologies to redefine gold production and ownership in the 21st century [6][7] Tokenization Strategy - The gold supply agreement directly supports Blue Gold's Tokenization Division, which aims to convert physical gold into digitally verifiable, asset-backed coins under the Standard Gold Coin brand [4] - The integration of physical mining, supply, and digital distribution creates a vertically aligned model designed for scalability and transparency in the tokenization of real-world assets [4]

Commercial framework positions the AirJoule™ platform technology to deliver pure distilled water using waste heat at unprecedented industrial scaleRONAN, Mont., Dec. 02, 2025 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AirJoule Technologies” or “AIRJ”), today identified Nexus Data Centers (“Nexus”) as the AI hyperscale data center developer previously referenced in its June 2025 memorandum of understanding (“MOU”) press release and is now accelerating the first deployment of AirJo ...

DURHAM, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), today announced that Pelthos’ CEO Scott Plesha will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference (the “Conference”) on December 4, 2025 at 9:30 a.m. Eastern Time at The Lotte New York Palace located at 455 Madison Avenue, New York, NY 10022. Instit ...

Teledyne DALSA's Xtium3 Teledyne’s Xtium3 PCIe Gen4 frame grabber series MONTREAL, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Teledyne DALSA, a Teledyne Technologies [NYSE: TDY] company, announces the release of the Xtium™3 PCIe Gen4 family, a next-generation frame grabber engineered to deliver maximum sustained throughput and ready-to-use image data for high-performance industrial applications. Building on the proven Xtium2 platform, the first model, Xtium3-CLHS PX8 supports the Camera Link HS® (CLHS) standard ...

VANCOUVER, Wash., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business management solutions and one of the largest professional employer organizations (PEO) in the U.S., is proud to announce that for the fifth year in a row, the company has been Certified™ by Great Place To Work®. This prestigious award is based entirely on what current employees say about their experience working at BBSI. “We are honored to be recognized as a Great Place To ...

Proven commercial leader with 20+ years of experience driving revenue growth and market adoption for early-stage and high-growth MedTech companiesStrong track record of launching breakthrough technologies across spine, neurosurgery and pain managementStrengthens Aclarion’s commercial execution as the Company expands adoption and payer engagement across the Eastern U.S. BROOMFIELD, Colo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare techn ...

TORONTO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- DPM Metals Inc. (TSX: DPM, ASX: DPM) (ARBN: 689370894) (“DPM” or “the Company”) is pleased to announce initial Mineral Resource Estimates (“MRE”) for the Dumitru Potok, Rakita North and Frasen prospects in eastern Serbia, all located within one to two kilometres of planned Čoka Rakita infrastructure. Highlights Establishes a potential district scale platform, with a combined Inferred MRE of 84.4 million tonnes at a grade of 0.97 g/t gold and 1.02% copper for 2.6 mi ...

Core Insights - The study published in Pain Physician shows that iovera° cryoneurolysis significantly improves functional outcomes for chronic low back pain patients compared to radiofrequency ablation (RFA) [1][6] - Patients treated with iovera° experienced lower pain scores and improved functional disability over a 12-month period [8] Study Findings - The pilot study involved 30 patients with facet-mediated chronic low back pain, comparing iovera° to RFA [4] - At 180 days, pain scores for iovera° patients were 3.1 compared to 5.4 for RFA patients (p=0.01) [8] - At 360 days, pain scores for iovera° patients were 3.0 compared to 6.1 for RFA patients (p=0.01) [8] - Functional disability, measured by the Oswestry Disability Index (ODI), showed iovera° patients scoring 10.1 at 360 days versus 20.6 for RFA patients (p=0.002) [8] - Fewer iovera° patients required additional spine injections after 180 days, with 45.5% needing further treatment compared to 75% of RFA patients [8] - No treatment-related adverse events were reported in either group during the 12-month follow-up [8] Treatment Mechanism - The iovera° system utilizes cryoneurolysis, applying focused cold therapy to targeted nerves to interrupt pain signal transmission [2][8] - Pain relief is typically immediate and can last up to 90 days as the nerve regenerates [2][9] Industry Context - Chronic low back pain is a leading cause of disability in the U.S. and contributes significantly to opioid use [3] - The need for alternative, tissue-sparing approaches like cryoneurolysis is underscored by the potential tissue damage associated with RFA [3] - The FDA recently cleared a new SmartTip for iovera° to allow deeper nerve access for lumbar applications, supporting ongoing clinical evidence expansion [6]

SINGAPORE, Dec. 02, 2025 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd (Nasdaq: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced that the Company will be participating in the upcoming Benchmark Discovery One-on-One Conference in New York City. Benchmark’s 14th Annual Discovery One-on-One Conference 1x1 in-person meetings Who: Sebastian Toke, Group CEO When: December 4, 2025, 8:45pm – 3:40pm Eastern Where: New York Athletic Club in New York City About GCL Global Ho ...

VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Refined Energy Corp. (CSE: RUU | OTC: RRUUF | FRA: CWA0) ("Refined” or the "Company") is pleased to announce the appointment of veteran uranium explorer Ken Wheatley to its Board of Directors. Mr. Wheatley is a Professional Geoscientist registered with the Association of Professional Engineers and Geoscientists of Saskatchewan and brings more than 44 years of uranium exploration expertise across Canada’s premier mining jurisdictions. Since begin ...